Interleukin 2 (IL-2) is a key growth factor for the clonal expansion of antigen activated T lymphocytes whose biological activity is mediated by binding to the high affinity IL-2 receptor (IL-2R), comprised of 3 subunits, alpha, beta and gamma. Signal transduction via the IL-2R is dependent upon the cytoplasmic tails of the beta and gamma subunits. The gamma subunit (designated gamma-c) has been recently shown to be a component of the lL-4 receptor (IL-4R) and IL-7 receptor (IL-7R), and it is highly likely a component of the IL-9R and lL-15R. Proper signal transduction from gamma-c is critical for normal lymphocyte development as mutations in the human gamma-c gene has been causally associated with X- linked severe combined immunodeficiency disease (SCID). A key issue, therefore, for understanding how not only the IL-2R but also cytokine receptors in general regulate the immune system is to establish the function of gamma-c. During the last grant period, cDNA probes and unique monoclonal antibodies (mAbs) to the IL-2Rbeta and gamma-c were generated to facilitate study of the mouse IL-2R. An in vivo system have been developed that appears to be a mouse model of X-linked SCID. By adoptive transfer of bone marrow cells and subsequent treatment of the recipient with mAbs to gamma-c, preliminary data demonstrate that gamma-c bearing cells are required for mouse T and B cell development from progenitor cells in adult bone marrow. The major objectives of this proposal are to establish the contribution of the gamma-c in T lymphocyte development and to define the physiological relevant role of cytoplasmic domains of IL-2Rbeta and gamma-c in T cell growth and differentiation into effector cells.
The specific aims are: 1) To establish the contribution of gamma-c on T and B lymphocyte development from embryonic and adult bone marrow progenitor cells; 2) to delineate whether gamma-c signalling promotes intrathymic T cell development: and 3) to determine the functional activity of lL-2Rbeta and gamma-c signal transducing modules in normal T lymphocytes. The first 2 aims will by pursued by detailed characterization of the anti-gamma-c mouse model of SCID and by production and characterization of dominant negative transgenic mice in which gamma-c signalling is inhibited in distinct cellular compartments.
For aim 3 chimeric IL-2R will be expressed in transgenic mice that are akin to producing a """"""""knockout"""""""" mouse in which discrete functional cytoplasmic domains of IL-2Rbeta or gamma-c have been mutated to test the contribution of that domain on T cell growth and differentiation into effector cells by normal T lymphocytes.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG5-EI (03))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Miami School of Medicine
Schools of Medicine
United States
Zip Code
Cheng, Guoyan; Yu, Aixin; Dee, Michael J et al. (2013) IL-2R signaling is essential for functional maturation of regulatory T cells during thymic development. J Immunol 190:1567-75
Cheng, Guoyan; Yuan, Xiaomei; Tsai, Matthew S et al. (2012) IL-2 receptor signaling is essential for the development of Klrg1+ terminally differentiated T regulatory cells. J Immunol 189:1780-91
Yuan, Xiaomei; Malek, Thomas R (2012) Cellular and molecular determinants for the development of natural and induced regulatory T cells. Hum Immunol 73:773-82
Cheng, Guoyan; Yu, Aixin; Malek, Thomas R (2011) T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells. Immunol Rev 241:63-76
Malek, Thomas R; Castro, Iris (2010) Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity 33:153-65
Yu, Aixin; Zhu, Linjian; Altman, Norman H et al. (2009) A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells. Immunity 30:204-17
Bayer, Allison L; Lee, Joon Youb; de la Barrera, Anabel et al. (2008) A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells. J Immunol 181:225-34
Yu, Aixin; Malek, Thomas R (2006) Selective availability of IL-2 is a major determinant controlling the production of CD4+CD25+Foxp3+ T regulatory cells. J Immunol 177:5115-21
Adeegbe, Dennis; Bayer, Allison L; Levy, Robert B et al. (2006) Cutting edge: allogeneic CD4+CD25+Foxp3+ T regulatory cells suppress autoimmunity while establishing transplantation tolerance. J Immunol 176:7149-53
Jin, Haoli; Carrio, Roberto; Yu, Aixin et al. (2004) Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis. J Immunol 173:657-65

Showing the most recent 10 out of 20 publications